RSS-Feed abonnieren
DOI: 10.1055/s-0038-1660795
Endovascular Treatment for Variceal Hemorrhage: TIPS, BRTO, and Combined Approaches
Publikationsverlauf
Publikationsdatum:
06. August 2018 (online)
![](https://www.thieme-connect.de/media/sir/201803/lookinside/thumbnails/10-1055-s-0038-1660795_001073-1.jpg)
Abstract
Variceal hemorrhage is a feared complication of portal hypertension, with high rates of morbidity and mortality. Optimal management requires a thoughtful, multidisciplinary approach. In cases of refractory or recurrent esophageal hemorrhage, endovascular approaches such as transjugular intrahepatic portosystemic shunt (TIPS) have a well-defined role. For hemorrhage related to gastric varices, the optimal treatment remains to be established; however, there is increasing adoption of balloon-occluded retrograde transvenous obliteration (BRTO). This article will review the concept, history, patient selection, basic technique, and outcomes for TIPS, BRTO, and combined TIPS + BRTO procedures for variceal hemorrhage.
-
References
- 1 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44 (01) 217-231
- 2 Mallet M, Rudler M, Thabut D. Variceal bleeding in cirrhotic patients. Gastroenterol Rep (Oxf) 2017; 5 (03) 185-192
- 3 Saad WEA, Darcy MD. Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices. Semin Intervent Radiol 2011; 28 (03) 339-349
- 4 Saad WE. combining transjugular intrahepatic portosystemic shunt with balloon-occluded retrograde transvenous obliteration or augmenting TIPS with variceal embolization for the management of gastric varices: an evolving middle ground?. Semin Intervent Radiol 2014; 31 (03) 266-268
- 5 Fernandez M, Abraldes JG. Gastroesophageal varices. In: Muriel P. , ed. Liver Pathophysiology: Therapies and Antioxidants. New York, NY: Elsevier; 2017: 451-473
- 6 Groszmann RJ, Garcia-Tsao G, Bosch J. , et al; Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005; 353 (21) 2254-2261
- 7 Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc 2007; 65 (01) 82-88
- 8 Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16 (06) 1343-1349
- 9 Kim T, Shijo H, Kokawa H. , et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997; 25 (02) 307-312
- 10 Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017; 65 (01) 310-335
- 11 de Franchis R, Pascal JP, Ancona E. , et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992; 15 (1–2): 256-261
- 12 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. ; Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46 (03) 922-938
- 13 Christensen E, Fauerholdt L, Schlichting P, Juhl E, Poulsen H, Tygstrup N. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology 1981; 81 (05) 944-952
- 14 Merli M, Nicolini G, Angeloni S. , et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003; 38 (03) 266-272
- 15 Gulamhusein AF, Kamath PS. The epidemiology and pathogenesis of gastrointestinal varices. Tech Gastrointest Endosc 2017; 19 (02) 62-68
- 16 Merkel C, Marin R, Angeli P. , et al; Gruppo Triveneto per l'Ipertensione Portale. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 2004; 127 (02) 476-484
- 17 Chao Y, Lin H-C, Lee F-Y. , et al. Hepatic hemodynamic features in patients with esophageal or gastric varices. J Hepatol 1993; 19 (01) 85-89
- 18 Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices. A study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 1988; 95 (02) 434-440
- 19 Polio J, Groszmann RJ. Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin Liver Dis 1986; 6 (04) 318-331
- 20 Polio J, Groszmann RJ, Reuben A, Sterzel RB, Better OS. Portal hypertension ameliorates arterial hypertension in spontaneously hypertensive rats. J Hepatol 1989; 8 (03) 294-301
- 21 Berzigotti A. Advances and challenges in cirrhosis and portal hypertension. BMC Med 2017; 15 (01) 200
- 22 Gaba RC, Couture PM, Lakhoo J. Gastroesophageal variceal filling and drainage pathways: an angiographic description of afferent and efferent venous anatomic patterns. J Clin Imaging Sci 2015; 5 (01) 61-66
- 23 Merkel C, Zoli M, Siringo S. , et al. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol 2000; 95 (10) 2915-2920
- 24 El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol 2000; 95 (12) 3566-3573
- 25 D'Amico G, De Franchis R. ; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38 (03) 599-612
- 26 Carbonell N, Pauwels A, Serfaty L, Fourdan O, Lévy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004; 40 (03) 652-659
- 27 Reverter E, Tandon P, Augustin S. , et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 2014; 146 (02) 412-19.e3
- 28 D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999; 19 (04) 475-505
- 29 Bosch J, García-Pagán JC. Prevention of variceal rebleeding. Lancet 2003; 361 (9361): 952-954
- 30 Moitinho E, Escorsell A, Bandi JC. , et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999; 117 (03) 626-631
- 31 Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L. , et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004; 40 (04) 793-801
- 32 Morrison JD, Mendoza-Elias N, Lipnik AJ. , et al. Gastric varices bleed at lower portosystemic pressure gradients than esophageal varices. J Vasc Interv Radiol 2018; 29 (05) 636-641
- 33 Tripathi D, Therapondos G, Jackson E, Redhead DN, Hayes PC. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002; 51 (02) 270-274
- 34 Mishra SR, Chander Sharma B, Kumar A, Sarin SK. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut 2010; 59 (06) 729-735
- 35 Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Correlation between endoscopic and angiographic findings in patients with esophageal and isolated gastric varices. Dig Surg 2001; 18 (03) 176-181
- 36 Kiyosue H, Ibukuro K, Maruno M, Tanoue S, Hongo N, Mori H. Multidetector CT anatomy of drainage routes of gastric varices: a pictorial review. Radiographics 2013; 33 (01) 87-100
- 37 de Franchis R. ; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63 (03) 743-752
- 38 García-Pagán JC, Reverter E, Abraldes JG, Bosch J. Acute variceal bleeding. Semin Respir Crit Care Med 2012; 33 (01) 46-54
- 39 Rösch J. Development of transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 2015; 26 (02) 220-222
- 40 Rösch J, Hanafee WN, Snow H. Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology 1969; 92 (05) 1112-1114
- 41 Rössle M. TIPS: 25 years later. J Hepatol 2013; 59 (05) 1081-1093
- 42 Rösch J, Hanafee W, Snow H, Barenfus M, Gray R. Transjugular intrahepatic portacaval shunt. An experimental work. Am J Surg 1971; 121 (05) 588-592
- 43 Gutierrez OH, Burgener FA. Production of nonsurgical portosystemic venous shunts in dogs by transjugular approach. Radiology 1979; 130 (02) 507-509
- 44 Colapinto RF, Stronell RD, Birch SJ. , et al. Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter. Can Med Assoc J 1982; 126 (03) 267-268
- 45 Gordon JD, Colapinto RF, Abecassis M. , et al. Transjugular intrahepatic portosystemic shunt: a nonoperative approach to life-threatening variceal bleeding. Can J Surg 1987; 30 (01) 45-49
- 46 Palmaz JC, Garcia F, Sibbitt RR. , et al. Expandable intrahepatic portacaval shunt stents in dogs with chronic portal hypertension. AJR Am J Roentgenol 1986; 147 (06) 1251-1254
- 47 Rössle M, Richter GM, Nöldge G, Palmaz JC, Wenz W, Gerok W. New non-operative treatment for variceal haemorrhage. Lancet 1989; 2 (8655): 153
- 48 Rössle M, Richter GM, Noeldge G. , et al. The intrahepatic portosystemic shunt. Initial clinical experiences with patients with liver cirrhosis [in German]. Dtsch Med Wochenschr 1989; 114 (40) 1511-1516
- 49 Richter GM, Palmaz JC, Nöldge G. , et al. The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method [in German]. Radiologe 1989; 29 (08) 406-411
- 50 Richter GM, Noeldge G, Palmaz JC, Roessle M. The transjugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study. Cardiovasc Intervent Radiol 1990; 13 (03) 200-207
- 51 LaBerge JM, Ring EJ, Gordon RL. Transjugular intrahepatic portosystenlic shunts: TIPS. Surg Technol Int 1991; I: 300-305
- 52 Haskal ZJ, Scott M, Rubin RA, Cope C. Intestinal varices: treatment with the transjugular intrahepatic portosystemic shunt. Radiology 1994; 191 (01) 183-187
- 53 Sterling KM, Darcy MD. Stenosis of transjugular intrahepatic portosystemic shunts: presentation and management. AJR Am J Roentgenol 1997; 168 (01) 239-244
- 54 Saxon RR, Mendel-Hartvig J, Corless CL. , et al. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine. J Vasc Interv Radiol 1996; 7 (04) 487-497
- 55 Wilkins LR, Sabri SS. Nonendoscopic management of gastric varices. Tech Gastrointest Endosc 2017; 19 (02) 96-100
- 56 Charon JP, Alaeddin FH, Pimpalwar SA. , et al. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2004; 15 (11) 1219-1230
- 57 Jung HS, Kalva SP, Greenfield AJ. , et al. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts. J Vasc Interv Radiol 2009; 20 (02) 180-185
- 58 Kalva SP, Salazar GM, Walker TG. Transjugular intrahepatic portosystemic shunt for acute variceal hemorrhage. Tech Vasc Interv Radiol 2009; 12 (02) 92-101
- 59 Boyer TD, Haskal ZJ. ; American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010; 51 (01) 306
- 60 Dariushnia SR, Haskal ZJ, Midia M. , et al; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2016; 27 (01) 1-7
- 61 Gaba RC, Omene BO, Podczerwinski ES. , et al. TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period. J Vasc Interv Radiol 2012; 23 (02) 227-235
- 62 Gaba RC, Khiatani VL, Knuttinen MG. , et al. Comprehensive review of TIPS technical complications and how to avoid them. AJR Am J Roentgenol 2011; 196 (03) 675-685
- 63 Sommer CM, Gockner TL, Stampfl U. , et al. Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus viatorr stent-grafts (VSG). Eur J Radiol 2012; 81 (09) 2273-2280
- 64 Gaba RC, Parvinian A, Minocha J. , et al. Should transjugular intrahepatic portosystemic shunt stent grafts be underdilated?. J Vasc Interv Radiol 2015; 26 (03) 382-387
- 65 Taylor AG, Kolli KP, Kerlan Jr RK. Techniques for transjugular intrahepatic portosystemic shunt reduction and occlusion. Tech Vasc Interv Radiol 2016; 19 (01) 74-81
- 66 Sahagun G, Benner KG, Saxon R. , et al. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage. Am J Gastroenterol 1997; 92 (09) 1444-1452
- 67 Lopera JE. Role of emergency transjugular intrahepatic portosystemic shunts. Semin Intervent Radiol 2005; 22 (04) 253-265
- 68 Loffroy R, Favelier S, Pottecher P. , et al. Transjugular intrahepatic portosystemic shunt for acute variceal gastrointestinal bleeding: Indications, techniques and outcomes. Diagn Interv Imaging 2015; 96 (7–8): 745-755
- 69 Martin M, Zajko AB, Orons PD. , et al. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery 1993; 114 (04) 719-726 , discussion 726–727
- 70 Bizollon T, Dumortier J, Jouisse C. , et al. Transjugular intra-hepatic portosystemic shunt for refractory variceal bleeding. Eur J Gastroenterol Hepatol 2001; 13 (04) 369-375
- 71 Rössle M. When endoscopic therapy or pharmacotherapy fails to control variceal bleeding: what should be done? Immediate control of bleeding by TIPS?. Langenbecks Arch Surg 2003; 388 (03) 155-162
- 72 Tesdal IK, Filser T, Weiss C, Holm E, Dueber C, Jaschke W. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. Radiology 2005; 236 (01) 360-367
- 73 Qi X, Liu L, Bai M. , et al. Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis. J Gastroenterol Hepatol 2014; 29 (04) 688-696
- 74 Wu X-J, Cao J-M, Han J-M, Li J-S. Long-term results of TIPS, TIPS with CVO and combined TIPS and portal azygous disconnection for the treatment of portal hypertension [in Chinese]. Zhonghua Wai Ke Za Zhi 2009; 47 (06) 446-449
- 75 Wei B, Chen S, Li X, Tang CW. Prevention of variceal rebleeding by TIPS combined with embolization of gastric coronary veins: a clinical controlled study [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 2011; 19 (07) 494-497
- 76 Chen S, Li X, Wei B. , et al. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. Radiology 2013; 268 (03) 900-906
- 77 Shi Y, Tian X, Hu J. , et al. Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding. Dig Dis Sci 2014; 59 (09) 2325-2332
- 78 Xiao T, Chen L, Chen W. , et al. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study. J Clin Gastroenterol 2011; 45 (07) 643-650
- 79 Xue H, Yuan J, Chao-Li Y. , et al. Follow-up study of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension. Dig Dis Sci 2011; 56 (11) 3350-3356
- 80 García-Pagán JC, Caca K, Bureau C. , et al; Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362 (25) 2370-2379
- 81 Garcia-Pagán JC, Di Pascoli M, Caca K. , et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol 2013; 58 (01) 45-50
- 82 Tripathi D, Ferguson J, Barkell H. , et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol 2006; 18 (03) 225-232
- 83 Wan YM, Li YH, Xu Y. , et al. Predictors of shunt dysfunction and overall survival in patients with variceal bleeding treated with transjugular portosystemic shunt creation using the fluency stent graft. Acad Radiol 2018; (e-pub ahead of print) DOI: 10.1016/j.acra.2017.11.020.
- 84 Triantafyllou T, Aggarwal P, Gupta E, Svetanoff WJ, Bhirud DP, Singhal S. Polytetrafluoroethylene-covered stent graft versus bare stent in transjugular intrahepatic portosystemic shunt: systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A 2018; (e-pub ahead of print) DOI: 10.1089/lap.2017.0560.
- 85 Gaba RC. Transjugular intrahepatic portosystemic shunt creation with embolization or obliteration for variceal bleeding. Tech Vasc Interv Radiol 2016; 19 (01) 21-35
- 86 Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. “Salvage” transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114 (05) 981-987
- 87 Barange K, Péron JM, Imani K. , et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999; 30 (05) 1139-1143
- 88 Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol 2003; 4 (02) 109-116
- 89 Mahadeva S, Bellamy MC, Kessel D, Davies MH, Millson CE. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol 2003; 98 (12) 2688-2693
- 90 Lo GH, Liang HL, Chen WC. , et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007; 39 (08) 679-685
- 91 Procaccini NJ, Al-Osaimi AMS, Northup P, Argo C, Caldwell SH. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc 2009; 70 (05) 881-887
- 92 Anderson CL, Saad WEA, Kalagher SD. , et al. Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience. J Vasc Interv Radiol 2010; 21 (09) 1370-1376
- 93 Lin L-L, Du S-M, Fu Y. , et al. Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials. Oncotarget 2017; 8 (34) 57399-57408
- 94 Koulia K, Brountzos EN. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. Ann Gastroenterol 2013; 26 (02) 180-181
- 95 Rudler M, Cluzel P, Corvec TL. , et al. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. Aliment Pharmacol Ther 2014; 40 (09) 1074-1080
- 96 Halabi SA, Sawas T, Sadat B. , et al. Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2016; 31 (09) 1519-1526
- 97 Njei B, McCarty TR, Laine L. Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding. J Gastroenterol Hepatol 2017; 32 (04) 852-858
- 98 Thabut D, Pauwels A, Carbonell N. , et al; des Hépato-Gastroentérologues des Hôpitaux Généraux (ANGH). Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results. J Hepatol 2017; (e-pub ahead of print) DOI: 10.1016/j.jhep.2017.09.002.
- 99 Stanley AJ, Jalan R, Ireland HM, Redhead DN, Bouchier IA, Hayes PC. A comparison between gastric and oesophageal variceal haemorrhage treated with transjugular intrahepatic portosystemic stent shunt (TIPSS). Aliment Pharmacol Ther 1997; 11 (01) 171-176
- 100 Sanyal AJ, Freedman AM, Luketic VA. , et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997; 112 (03) 889-898
- 101 Lakhoo J, Bui JT, Lokken RP, Ray Jr CE, Gaba RC. Transjugular intrahepatic portosystemic shunt creation and variceal coil or plug embolization ineffectively attain gastric variceal decompression or occlusion: results of a 26-patient retrospective study. J Vasc Interv Radiol 2016; 27 (07) 1001-1011
- 102 Olson E, Yune HY, Klatte EC. Transrenal-vein reflux ethanol sclerosis of gastroesophageal varices. AJR Am J Roentgenol 1984; 143 (03) 627-628
- 103 Richter GM, Noeldge G, Roessle M, Palmaz JC. Evolution and clinical introduction of TIPSS, the transjugular intrahepatic portosystemic stent-shunt. Semin Intervent Radiol 1991; 8 (04) 331-340
- 104 Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 1996; 11 (01) 51-58
- 105 Takuma Y, Nouso K, Makino Y, Saito S, Shiratori Y. Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis. Clin Gastroenterol Hepatol 2005; 3 (12) 1245-1252
- 106 Araki T, Hori M, Motosugi U. , et al. Can balloon-occluded retrograde transvenous obliteration be performed for gastric varices without gastrorenal shunts?. J Vasc Interv Radiol 2010; 21 (05) 663-670
- 107 Sabri SS, Saad WEA. Balloon-occluded retrograde transvenous obliteration (BRTO): technique and intraprocedural imaging. Semin Intervent Radiol 2011; 28 (03) 303-313
- 108 Koizumi J, Hashimoto T, Myojin K. , et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: use of CT-guided foam sclerotherapy to optimize technique. AJR Am J Roentgenol 2012; 199 (01) 200-207
- 109 Saad WE, Kitanosono T, Koizumi J, Hirota S. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications. Tech Vasc Interv Radiol 2013; 16 (02) 101-151
- 110 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features. Radiographics 2003; 23 (04) 921-937 , discussion 937
- 111 Patel A, Fischman AM, Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices. AJR Am J Roentgenol 2012; 199 (04) 721-729
- 112 Saad WE, Nicholson D, Koizumi J. Inventory used for balloon-occluded retrograde (BRTO) and antegrade (BATO) transvenous obliteration: sclerosants and balloon occlusion devices. Tech Vasc Interv Radiol 2012; 15 (03) 226-240
- 113 Saad WE, Nicholson DB. Optimizing logistics for balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices by doing away with the indwelling balloon: concept and techniques. Tech Vasc Interv Radiol 2013; 16 (02) 152-157
- 114 Lee EW, Saab S, Gomes AS. , et al. Coil-assisted retrograde transvenous obliteration (CARTO) for the treatment of portal hypertensive variceal bleeding: preliminary results. Clin Transl Gastroenterol 2014; 5: e61
- 115 Gwon DI, Ko GY, Yoon HK. , et al. Gastric varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge-assisted retrograde transvenous obliteration--a primary report. Radiology 2013; 268 (01) 281-287
- 116 Park JK, Saab S, Kee ST. , et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis. Dig Dis Sci 2015; 60 (06) 1543-1553
- 117 Cho SK, Shin SW, Do YS. , et al. Development of thrombus in the major systemic and portal veins after balloon-occluded retrograde transvenous obliteration for treating gastric variceal bleeding: its frequency and outcome evaluation with CT. J Vasc Interv Radiol 2008; 19 (04) 529-538
- 118 Park SJ, Chung JW, Kim HC, Jae HJ, Park JH. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. J Vasc Interv Radiol 2010; 21 (04) 503-507
- 119 Sabri SS, Swee W, Turba UC. , et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol 2011; 22 (03) 309-316 , quiz 316
- 120 Arai H, Abe T, Takayama H. , et al. Respiratory effects of balloon occluded retrograde transvenous obliteration of gastric varices: a prospective controlled study. J Gastroenterol Hepatol 2011; 26 (09) 1389-1394
- 121 Ninoi T, Nishida N, Kaminou T. , et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol 2005; 184 (04) 1340-1346
- 122 Watanabe M, Shiozawa K, Ikehara T. , et al. Short-term effects and early complications of balloon-occluded retrograde transvenous obliteration for gastric varices. ISRN Gastroenterol 2012; 2012: 919371
- 123 Wang YB, Zhang JY, Gong JP, Zhang F, Zhao Y. Balloon-occluded retrograde transvenous obliteration versus transjugular intrahepatic portosystemic shunt for treatment of gastric varices due to portal hypertension: A meta-analysis. J Gastroenterol Hepatol 2016; 31 (04) 727-733
- 124 Saad WE, Wagner CC, Lippert A. , et al. Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). Am J Gastroenterol 2013; 108 (10) 1612-1619
- 125 Farsad K, Fuss C, Kolbeck KJ. , et al. Transjugular intrahepatic portosystemic shunt creation using intravascular ultrasound guidance. J Vasc Interv Radiol 2012; 23 (12) 1594-1602
- 126 Harman JT, Reed JD, Kopecky KK, Harris VJ, Haggerty MF, Strzembosz AS. Localization of the portal vein for transjugular catheterization: percutaneous placement of a metallic marker with real-time US guidance. J Vasc Interv Radiol 1992; 3 (03) 545-547
- 127 Wenz F, Nemcek Jr AA, Tischler HA, Minor PL, Vogelzang RL. US-guided paraumbilical vein puncture: an adjunct to transjugular intrahepatic portosystemic shunt (TIPS) placement. J Vasc Interv Radiol 1992; 3 (03) 549-551
- 128 Warner DL, Owens CA, Hibbeln JF, Ray Jr CE. Indirect localization of the portal vein during a transjugular intrahepatic portosystemic shunt procedure: placement of a radiopaque marker in the hepatic artery. J Vasc Interv Radiol 1995; 6 (01) 87-89 , discussion 89–90